Displaying 10 out of 13 results

  1. A trader works at the post that trades Parsley Energy Inc. and  Allergan Plc., on the floor of the

    Allergan promises independent board chair in next leadership change

    Allergan Plc plans to elect an independent board chairman, starting with the next leadership transition, the Botox maker said on Friday, as the ...
  2. David Tepper, founder of Apploosa Management, speaks during the Sohn Investment Conference in New Y

    Appaloosa's Tepper says Allergan should consider selling itself

    Billionaire hedge fund manager David Tepper said on Tuesday Allergan Plc should consider selling itself if its management is unable to turn around ...
  3. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    J&J becomes first drugmaker to add prices to television ads

    Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first ...
  4. FILE PHOTO: Ken Frazier, Chairman and CEO, Merck & Co., speaks during a meeting of the Economic

    Merck CEO Frazier to testify at Senate drug pricing hearing

    U.S. drug company Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans to testify at a Senate hearing later this month ...
  5. FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel

    Novartis urges Britain to secure drug supplies before Brexit

    Swiss drugmaker Novartis said it was building inventory of medicines in the UK as part of its preparation for Britain's looming exit from the ...
  6. The GSK logo is seen on top of GSK Asia House in Singapore

    GSK Chairman Hampton to step down ahead of split

    GlaxoSmithKline plc Chairman Philip Hamptonwill step down after more than three and a half years in the role, the drugmaker announced on Monday.
  7. FILE PHOTO: Used blister packets that contained medicines, tablets and pills are seen, in this pict

    Pharma industry returns on R&D investment hit nine-year low

    The cost of developing a new drug has nearly doubled since 2010 and the world's 12 biggest drugmakers are making the lowest return on their R&D ...
  8. The GSK logo on the facade of GSK Asia House is seen through vertical louvres in Singapore

    GSK to buy cancer drugmaker Tesaro for US$5.1 billion

    GlaxoSmithKline said on Monday it had agreed to buy U.S. cancer drug specialist Tesaro for US$5.1 billion, marking a major biotech investment by ...
  9. FILE PHOTO: The Walmart logo is displayed on a screen on the floor of the NYSE in New York

    Walmart, Home Depot adopt health insurer tactic in drug copay battle

    Walmart and Home Depot , two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount ...
  10. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources

    EU antitrust regulators are set to approve Japanese drugmaker Takeda Pharmaceutical's US$62-billion offer for London peer Shire on condition that ...